myelodysplastic syndrome
Showing NaN - NaN of 29
Chronic Myelomonocytic Leukemia, Chronic Myelomonocytic Leukemia-1, Chronic Myelomonocytic Leukemia-2 Trial in Canada, United
Active, not recruiting
- Chronic Myelomonocytic Leukemia
- +6 more
- Azacitidine
- +3 more
-
Birmingham, Alabama
- +297 more
Jan 28, 2023
Acute Myeloid Leukemia, Down Syndrome, Myelodysplastic Syndrome Trial in Worldwide (Asparaginase, Asparaginase Erwinia
Active, not recruiting
- Acute Myeloid Leukemia
- +4 more
- Asparaginase
- +7 more
-
Birmingham, Alabama
- +190 more
Jan 30, 2023
Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute Trial in Worldwide (Azacitidine,
Active, not recruiting
- Myelodysplastic Syndrome
- +2 more
-
Daphne, Alabama
- +241 more
Dec 23, 2022
Myelodysplastic Syndrome, MDS, Refractory Anemia With Excess Blasts Trial in Worldwide (rigosertib, Any approved or
Terminated
- Myelodysplastic Syndrome
- +3 more
- rigosertib
- +2 more
-
La Jolla, California
- +157 more
Sep 22, 2022
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Worldwide (FT-2102 (olutasidenib),
Active, not recruiting
- Acute Myeloid Leukemia
- +2 more
- FT-2102 (olutasidenib)
- +2 more
-
Los Angeles, California
- +59 more
Mar 2, 2022
Anemia, Chronic Myelomonocytic Leukemia, de Novo Myelodysplastic Syndrome Trial in United States (biological, other, drug)
Active, not recruiting
- Anemia
- +3 more
- Epoetin Alfa
- +2 more
-
Birmingham, Alabama
- +512 more
Mar 1, 2022
Cytogenetic Studies in Acute Leukemia and Multiple Myeloma
Active, not recruiting
- Acute Leukemia
- +3 more
- cytogenetic analysis
-
La Jolla, California
- +136 more
Aug 16, 2021
Myelodysplastic Syndrome, Iron Overload Trial in Canada, United States (Deferasirox)
Completed
- Myelodysplastic Syndrome
- Iron Overload
-
Birmingham, Alabama
- +47 more
Jul 21, 2021
Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in France, United States (oral
Completed
- Myelodysplastic Syndrome
- +2 more
- oral rigosertib
- Azacitidine
-
Gilbert, Arizona
- +12 more
Jun 15, 2021
Acute Myeloid Leukemia, de Novo Myelodysplastic Syndrome, Myelodysplastic Syndrome Trial in Chicago (Laboratory Biomarker
Completed
- Acute Myeloid Leukemia
- +4 more
- Laboratory Biomarker Analysis
- Selinexor
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
May 12, 2021
Leukemia, Myelodysplastic Syndrome, Multiple Myeloma Trial in Chicago (Fludarabine-Melphalan & Rabbit antithymocyte globulin
Completed
- Leukemia
- +3 more
- Fludarabine-Melphalan & Rabbit antithymocyte globulin (r-ATG)
- +4 more
-
Chicago, IllinoisThe University of Chicago
Jan 8, 2021
Myelodysplastic Syndrome, MDS Trial in Canada, United States (ASTX727 Dose Escalation, ASTX727 Dose Confirmation, ASTX727
Completed
- Myelodysplastic Syndrome
- MDS
- ASTX727 Dose Escalation
- +2 more
-
Phoenix, Arizona
- +16 more
Dec 1, 2020
Related Donors Donating PBSC to a Family Member, Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia Trial in United States
Completed
- Related Donors Donating PBSC to a Family Member
- +7 more
-
Tampa, Florida
- +11 more
Sep 3, 2020
Acute Myeloid Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in United States (FT-1101, Azacitidine)
Completed
- Acute Myeloid Leukemia
- +3 more
-
Los Angeles, California
- +7 more
Jun 25, 2019
Myelodysplastic Syndrome Trial in Worldwide (MEDI4736 Evaluate MEDI4736 in MDS, VIDAZA, tremelimumab)
Completed
- Myelodysplastic Syndrome
- MEDI4736 Evaluate MEDI4736 in MDS
- +2 more
-
Scottsdale, Arizona
- +20 more
May 9, 2019
Myelodysplastic Syndrome Trial in United States (vadastuximab talirine, Azacitidine, Placebo (for 33A))
Terminated
- Myelodysplastic Syndrome
- vadastuximab talirine
- +2 more
-
Gilbert, Arizona
- +33 more
Jan 23, 2019
Myelodysplastic Syndrome Trial in Chicago (CC-1088)
Completed
- Myelodysplastic Syndrome
-
Chicago, IllinoisRush-Presbyterian-St Luke's Medical Center
Apr 24, 2017
Myelodysplastic Syndrome Trial in Chicago (Panhematin)
Terminated
- Myelodysplastic Syndrome
-
Chicago, IllinoisRush University Medical Center
Oct 23, 2014
Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Chicago (Ara-C, Mitoxantrone, Etoposide)
Completed
- Myelodysplastic Syndrome
- Acute Myeloid Leukemia
- Ara-C
- +2 more
-
Chicago, IllinoisThe University of Chicago
Jan 16, 2014
Acute Myelogenous Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in United States (MLN4924, Azacitidine)
Completed
- Acute Myelogenous Leukemia
- +2 more
-
Stanford, California
- +5 more
Dec 3, 2013